about
Increased expression of ACTH (MC2R) and androgen (AR) receptors in giant bilateral myelolipomas from patients with congenital adrenal hyperplasiaNew evidences on the regulation of SF-1 expression by POD1/TCF21 in adrenocortical tumor cells.The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trialDevelopment of adrenal cortex zonation.Evaluation of Downstream Regulatory Element Antagonistic Modulator Gene in Human Multinodular Goiter.Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-cateninA new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.Mouse models of adrenocortical tumors.Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.Long-term Results after CT-Guided Percutaneous Ethanol Ablation for the Treatment of Hyperfunctioning Adrenal Disorders.Two Patients with Severe Short Stature due to a FBN1 Mutation (p.Ala1728Val) with a Mild Form of Acromicric Dysplasia.Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals.Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas.Molecular Mechanisms of Stem/Progenitor Cell Maintenance in the Adrenal Cortex.Genetics and epigenetics of adrenocortical tumors.Genetics of primary macronodular adrenal hyperplasia.Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer.Recurrent Hyperparathyroidism Due to a Novel CDC73 Splice Mutation.POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells.GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior.Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series.Age-dependent Increases in Adrenal Cytochrome b5 and Serum 5-Androstenediol-3-sulfate.Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.Identification of the first homozygous 1-bp deletion in GDF9 gene leading to primary ovarian insufficiency by using targeted massively parallel sequencing.A Novel Homozygous Missense FSHR Variant Associated with Hypergonadotropic Hypogonadism in Two Siblings from a Brazilian Family.Transcriptomic analysis of purified human cortical microglia reveals age-associated changes.PDX1 -MODY and dorsal pancreatic agenesis: New phenotype of a rare disease.Pathogenic copy number variants in patients with congenital hypopituitarism associated with complex phenotypes.Sonic Hedgehog and WNT Signaling Promote Adrenal Gland Regeneration in Male Mice.A novel homozygous 1-bp deletion in the NOBOX gene in two Brazilian sisters with primary ovarian failure.IHH Gene Mutations Causing Short Stature With Nonspecific Skeletal Abnormalities and Response to Growth Hormone Therapy.Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.Long-Term Outcomes and Molecular Analysis of a Large Cohort of Patients with 46,XY Disorder of Sex Development due to Partial Gonadal Dysgenesis.Female Patient with Alport Syndrome and Concomitant Membranous Nephropathy: Susceptibility or Association of Two Diseases?(18)F-FDG-PET/CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake.DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis.Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer.
P50
Q31162110-C5FA2703-C305-4A86-9B89-4562F2625F84Q33775898-4C562724-42B7-4C3D-B0F0-73EE1017743DQ34984126-2F91BAEE-97DE-48DA-A35D-66C8608B4092Q35800278-AFAC2601-AB17-40A6-9615-A8B6796DD32CQ36041622-B5375A12-C94E-427A-BA6B-08891141F447Q36204172-86D40E8D-1904-4E51-970E-42FE79AD47AEQ36340626-744442B9-A835-4D07-8998-CCCF62918D77Q36356051-1CF7A6C9-794F-420B-89F2-8F67154B6CAEQ36482758-D6330F15-3436-4DF6-BF83-D50790FF1806Q36688989-8EE7010E-B780-458C-8CF5-46BF9B3F9D44Q37320108-A576EC92-19FF-45DD-A582-CC02FCD2520AQ37470127-1B7CA49A-F553-4852-83AB-55D5F4DB21CAQ37696640-90CFB606-46E8-40A4-BA71-69439A6509C0Q37714445-34715606-E7F4-4367-A226-EA07E125D491Q37716736-2947EF3D-4E6A-4F86-9428-7CFA4914A0EAQ38162079-5FF9E76A-B3C0-4812-BD57-B19152927EDAQ38282796-D31853FE-9AF0-4A76-8561-52FC6A982E48Q38506337-57D86FFD-B5F6-42E2-8CAB-3CEB5D01FE41Q38844738-FF4992B7-B101-49CE-B972-BCA39A172966Q40483995-A3D5937A-23B0-47C3-98EF-5DDAA0A9F25EQ42362770-C825CB17-5BEC-4265-86A7-2B2A81D75575Q46950982-8081AE4F-552A-421E-B2D1-1B54A9129211Q46971744-C9AE899E-C706-4069-B7A3-C4484DC8445FQ47407589-1FBD67D9-9B4F-4D20-BB21-DA69973D5118Q47414379-A77C5AF7-D7BD-42C9-82C0-93172E46AC3FQ47606171-EF6E2DE4-945C-4168-8A78-5B67175EE322Q47738163-E8206FA4-3158-465D-9F3F-15876B01932FQ48186314-20A134E8-6EB2-4835-ADD4-C1177BBC6DAEQ48241195-D957CA1E-1329-49E0-8E0A-CA5357E28C30Q48370906-E7157DFB-F588-4A79-BE23-0B7423ADA9D9Q50049389-24B5A9E3-9F61-4AFF-950D-C99B7ECAABFBQ50079517-E2936B6A-0950-4027-83C5-5DE8A1147B41Q50181131-021BA81A-2ABD-4A96-A7BE-2495EBB78A31Q50203804-DDF741C7-AAE5-419F-B3DB-5CF5217A4F22Q51273946-F299808B-B7D8-4446-806E-26A92A4C971BQ52580897-D46CEF23-877A-4593-991C-2748D7111AC1Q52900127-776DEB97-E831-4544-9BFD-723EAB2450F3Q53192967-9125E54F-18C1-4400-A1ED-0518DDBE5356Q53219167-7105676E-004B-4C22-A7C1-11D8738E13CDQ54192420-3535F74F-A1D0-4C05-ABB0-64C6B3D4F513
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-8336-6432
@en
name
Antonio M Lerario
@ast
Antonio M Lerario
@en
Antonio M Lerario
@es
Antonio M Lerario
@nl
type
label
Antonio M Lerario
@ast
Antonio M Lerario
@en
Antonio M Lerario
@es
Antonio M Lerario
@nl
prefLabel
Antonio M Lerario
@ast
Antonio M Lerario
@en
Antonio M Lerario
@es
Antonio M Lerario
@nl
P106
P21
P31
P496
0000-0002-8336-6432